Who invested in Sayre Therapeutics?
Sayre Therapeutics's investors include InnoVen Capital.

Funding summaryUpdated 26 Oct 2026
$8.0Mraised across 1 round since 2017, from 1 source
Sayre Therapeutics's investors include InnoVen Capital.
Sayre Therapeutics has raised $8.0M across 1 round since 2017.
Sayre Therapeutics's most recent round was a Venture of $8.0M in Sept 2017.
Its most recent round, $8.0M in Sept 2017, is also its largest on record.
Sayre Therapeutics's first round on record, in Sept 2017, was backed by InnoVen Capital.
Sayre Therapeutics's latest named round is a Venture, in Sept 2017.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.